CS logo
small CS logo
Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants

Dallas, Texas, United States
Infectious disease physician in Dallas, Texas
3409 Worth St, Dallas, TX 75246

About Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants


"Our Dallas clinical research center is one of the most respected & sought-after locations in North Texas, specializing in infectious disease research."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants


During the past decade, Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants


According to Clinical.Site data, the most researched conditions in "Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants" are "COVID-19" (5 trials). Many other conditions were trialed in "Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants" in a lesser frequency.

Clinical Trials Intervention Types at Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants


Most popular intervention types in "Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants" are "Drug" (5 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Remdesivir" (5 trials), "Baricitinib" (2 trials), "Danicopan" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants


The vast majority of trials in "Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants" are 5 trials for "All" genders.

Clinical Trials Status at Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants


Currently, there are NaN active trials in "Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".